Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults
Clinical trial NCT00623181 · COMPLETED
Trial details
- NCT number
- NCT00623181
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.